2021

Privacy, Human Rights, new technologies Diversity, equity, and Inclusion (DE&I) After the crisis: Regulators strike back Legal vs. legitimate

ESG integration is the new normal — What investors expect now Disclosure strategy and internal collaboration across functional areas Best practice within and beyond biopharma

Hard and soft regulatory developments in key regions, especially the EU Biopharma sector response

Governance models, role and duty of boards, board competency Regulatory trends and codes of good practice

SASB Biotech & Pharma standards revision process Current developments: the Value Reporting Foundation, EU/EFRAG, IFRS

Measuring and valuing Patient and Social Impact Business model innovation for specific income bands or geographies Challenge of target-setting in the social dimension Science-based targets beyond Carbon The next big thing: Taxes? Biodiversity? Social taxonomy?   

Challenge of target-setting in the social dimension Science-based targets beyond Carbon The next big thing: Taxes? Biodiversity? Social taxonomy? 

The Biopharma Sustainability Roundtable (BSRT) and CECP’s CEO Investor Forum invite you to join nine leading leading biopharma CEOs for the first-ever sector-specific Biopharma CEO Investor Forum, June 7-8, 2021. CEOs from Catalent, GlaxoSmithKline, Incyte, Merck & Co., Moderna, Pfizer, Sanofi, Takeda, and UCB will share their Long-Term Plans for sustainable value creation with leading

Roundtable Forum with Eco:Fact Update on global hard and soft regulatory changes affecting biopharma Focus on EU: Green Deal, Circular Economy, Sustainable Finance, Non-Financial Reporting Directive Speaker: Olivier Jaeggi, Managing Director, ECO:FACT Video presentation is available to Roundtable members upon request. Please contact us if you are interested.

Roundtable Forum with Lise Kingo Biopharma sustainability oversight and governance priorities Speaker: Lise Kingo, Independent Director, Sanofi; former Executive Director, UN Global Compact Video presentation is available to Roundtable members upon request. Please contact us if you are interested.

Connecting Biopharma Sustainability and Long-Term Planning — A collaboration with CECP’s CEO Investor Forum. Initial release of our Executive Report and Practitioner’s Guide for integrating sustainability and long-term planning for biopharma companies.